← Back to all posts

July 24, 2026

Your AI Health Advice Is Only as Good as Your Subscription Tier — and That Should Alarm Every Business Owner

Imagine 300 million people asking the same tool for health guidance every single week, and half of them getting a measurably inferior answer simply because they haven't paid for an upgrade. That is…

Your AI Health Advice Is Only as Good as Your Subscription Tier — and That Should Alarm Every Business Owner

Imagine 300 million people asking the same tool for health guidance every single week, and half of them getting a measurably inferior answer simply because they haven't paid for an upgrade. That is not a hypothetical. That is what OpenAI just made real with the rollout of "Health in ChatGPT."

OpenAI officially launched "Health in ChatGPT" for U.S. users aged 18 and older after first unveiling and testing the feature in January 2026. The feature allows users to connect Apple Health data, medical records, and wellness apps directly to ChatGPT to review lab results, analyze sleep and activity data, and prepare for doctor appointments. OpenAI says connected health data will not be used for model training or advertising. More than 260 physicians helped develop the features. And yet, despite those reassurances, the platform draws a hard line between what free users and paying subscribers receive: free users get health responses powered by GPT-5.5 Instant, while paid subscribers get access to GPT-5.6 Sol, the stronger flagship model.

The performance gap between those two models is not trivial. On OpenAI's own HealthBench Professional benchmark, GPT-5.6 Sol outperforms physician-written answers in every category, with the largest gaps appearing in completeness, where Sol scores 88.0 percent versus 53.2 percent for GPT-5.5 Instant, and in health decision helpfulness, where Sol scores 83.0 percent versus 50.8 percent for Instant. That is a 35-point gap in completeness and a 32-point gap in health decision helpfulness, handed to you based entirely on whether you pay for a subscription. OpenAI will likely defend this two-tier system by noting that both models still outperform doctor-written answers on that benchmark, but critics rightly point out that benchmarks come from artificial test environments and cannot replicate what happens during an actual in-person exam, where a physician reads nonverbal cues, draws on patient history, and acknowledges the limits of their own certainty. In the radiology benchmark RadLE 2.0, none of the 16 AI models tested performed as well as human radiologists, and the primary failure mode was overconfidence: chatbots gave incorrect findings with high conviction rather than admitting uncertainty.

Usage figures reveal how deeply this tool is already embedded in everyday behavior. More than 300 million people ask ChatGPT health questions every week, a jump from 230 million reported in January 2026. OpenAI's own early testing found that more than 70 percent of participants asked health questions outside the dedicated Health section entirely, simply because switching to it was too cumbersome. That finding prompted the company to make the Health feature available in any conversation, while keeping the dedicated Health section for data management and accessing past health chats. The feature is currently U.S.-only. OpenAI has not announced a European launch date, and when the feature was first announced in January, it specifically excluded the European Economic Area, Switzerland, and the United Kingdom, likely due to stricter EU data privacy rules and the possibility that the feature could be classified as high-risk under the EU AI Act.

For small and mid-size business owners, this development carries implications that go well beyond healthcare. The "Health in ChatGPT" rollout is the clearest signal yet that AI tools are now tiered products, and the quality of output your team or your customers receive is directly tied to which subscription level they are using. If your business relies on AI-generated content, customer communications, research, or recommendations, and you are running those workflows on free-tier tools, you are not just accepting slower performance. You are accepting structurally inferior outputs compared to what competitors using paid tiers receive. The gap between free and paid AI is no longer a marginal difference in speed. It is increasingly a difference in accuracy, depth, and reliability.

There is also a trust dimension here that directly affects how businesses use AI-facing tools and how their customers perceive AI-generated information. OpenAI itself repeatedly states in its Health announcement that ChatGPT can still make mistakes and cannot replace medical advice. That caveat matters enormously in regulated or high-stakes categories like health, finance, and legal guidance. Businesses in or adjacent to those categories need to be especially thoughtful about which AI tier they are deploying, what disclosures they are making, and whether the tool's known failure modes, including overconfidence and sycophancy, could expose them to reputational or legal risk. AI that validates users rather than challenges false assumptions is a liability in any advisory context.

The most actionable thing you can do this week is audit every AI tool your business currently uses and identify which ones are running on free-tier models. Map those tools to the outputs they generate, whether that is customer emails, product descriptions, research summaries, or any form of recommendation. Then assess which of those outputs carry the highest stakes for your customers or your brand. For those high-stakes workflows, upgrade to the paid tier or switch to a model that benchmarks well in the relevant domain. The performance gaps documented in OpenAI's own HealthBench data are a reminder that "good enough" in AI is a moving target and that the distance between tiers is wider than most business owners realize.

The AI tools you choose, and the tier at which you use them, are now a strategic business decision, not a line-item expense to minimize.

Originally inspired by: ChatGPT will give you worse health advice if you don't pay (https://the-decoder.com/chatgpt-will-give-you-worse-health-advice-if-you-dont-pay/) See how Leads to Conversion can help you choose and deploy the right AI tools for your business. Get your free AI audit

← All postsGet Your Free Audit →